Announce Date | 02/05/2025 |
EPS Normalized Actual | $0.7 (Beat by $0.043) |
EPS GAAP Actual | $0.7 (Beat by $0.043) |
Revenue Actual | $4.561B |
Revenue Surprise | Beat by $4561M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.4325 | 21.77 | 4.26745 | 4.52688 | 1 |
Dec 2028 | 3.5375 | 27.27 | 3.45118 | 3.61931 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | 4.561B | 18.33% | 4561M |
FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 4.209B | 16.2% | 4209M |
FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 4.12B | 12.65% | 4120M |
FQ1 2024 (Mar 2024) | 0.34 | 0.34 | 3.856B | 12.11% | 3856M |
FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 3.725B | 12.97% | 3725M |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 3.527B | 10.12% | 3527M |
FQ2 2023 (Jun 2023) | 0.18 | 0.18 | 3.599B | 9.86% | 3599M |
FQ1 2023 (Mar 2023) | 0.21 | 0.21 | 3.389B | 100% | 3389M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.79 | -- | 0.77072 | 0.80273 | 13 |
FQ3 2027 (Jul 2027) | 0.8 | -- | 0.78048 | 0.81289 | 8 |
FQ2 2027 (Jun 2027) | 0.8 | -- | 0.7885 | 0.81581 | 7 |
FQ1 2027 (Mar 2027) | 0.74 | -- | 0.72936 | 0.75463 | 7 |
FQ4 2026 (Oct 2026) | 0.74344 | -- | 0.7253 | 0.75542 | 8 |
FQ3 2026 (Jul 2026) | 0.74363 | -- | 0.72548 | 0.75561 | 9 |
FQ2 2026 (Jun 2026) | 0.72387 | -- | 0.71347 | 0.73818 | 12 |
FQ1 2026 (Mar 2026) | 0.69028 | -- | 0.68036 | 0.70392 | 7 |
FQ4 2025 (Oct 2025) | 0.65238 | -- | 0.63646 | 0.66289 | 12 |
FQ3 2025 (Sep 2025) | 0.63828 | 49.87 | 0.62911 | 0.6509 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 4.98B | -- | 4.89B | 5.04B | 8 |
FQ3 2027 (Jul 2027) | 5.08B | -- | 4.98B | 5.14B | 8 |
FQ2 2027 (Jun 2027) | 5.08B | -- | 5.02B | 5.16B | 8 |
FQ1 2027 (Mar 2027) | 4.78B | -- | 4.72B | 4.85B | 8 |
FQ4 2026 (Oct 2026) | 4.79B | -- | 4.7B | 4.85B | 8 |
FQ3 2026 (Jul 2026) | 4.85B | -- | 4.76B | 4.91B | 8 |
FQ2 2026 (Jun 2026) | 4.67B | -- | 4.62B | 4.74B | 13 |
FQ1 2026 (Mar 2026) | 4.37B | -- | 4.32B | 4.44B | 8 |
FQ4 2025 (Oct 2025) | 4.34B | -5.06 | 4.26B | 4.4B | 7 |
FQ3 2025 (Sep 2025) | 4.23B | 0.54 | 4.19B | 4.3B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 100% | |
FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 100% | |
FQ1 2024 (Mar 2024) | 0.34 | 0.34 | 100% | |
FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 100% | |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 100% | |
FQ2 2023 (Jun 2023) | 0.18 | 0.18 | 100% | |
FQ1 2023 (Mar 2023) | 0.21 | 0.21 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $4.56B | $4561M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.21B | $4209M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.12B | $4120M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.86B | $3856M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.73B | $3725M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.53B | $3527M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.6B | $3599M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.39B | $3389M | 100% |